ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
17.75
+0.10 (0.57%)
Oct 19, 2026, 2:47 PM EDT - Market open
ADARx Pharmaceuticals Revenue
ADARx Pharmaceuticals had revenue of $746.00K in the quarter ending June 30, 2026, with 258.65% growth. This brings the company's total for the last twelve months to $6.13M. In the year 2025, ADARx Pharmaceuticals had annual revenue of $3.45M. That makes ADARx Pharmaceuticals the 39,283rd largest company in the world by revenue and 5,209th in the United States.
Revenue (ttm)
$6.13M
Revenue Growth
n/a
P/S Ratio
324.26
Revenue / Employee
$61,270
Employees
100
Market Cap
1.99B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.45M | - | - |
| Dec 31, 2024 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ADRX News
- 17 days ago - ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering - GlobeNewsWire
- 21 days ago - Opening Day: Amaero, Bamboo Insurance postpone IPOs - TheFly
- 24 days ago - ADARx Pharmaceuticals opens at $22.10, IPO priced at $17 per share - TheFly
- 24 days ago - ADARx Pharmaceuticals indicated to open at $24, IPO priced at $17 - TheFly
- 24 days ago - ADARx Pharmaceuticals indicated to open at $28, IPO priced at $17 - TheFly
- 24 days ago - ADARx Pharmaceuticals raises $446.3 million in upsized US IPO - Reuters
- 24 days ago - ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering - GlobeNewsWire
- 4 weeks ago - ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO - Reuters